Bovilix 1.21 g / 30 mL Lotion is a Health Canada–registered veterinary drug (DIN 00775290) held by Vortech Pharmaceuticals Ltd., containing Boric Acid. Health Canada lists its status as Cancelled Post Market (status date 18 Oct 1996). Nexara Health has matched 11 registrations of Boric Acid across 5 other regulated markets.
Health Canada registration
| DIN | 00775290 |
|---|---|
| Brand name | Bovilix |
| Active ingredient | Boric Acid |
| Strength | 1.21 g / 30 mL |
| Dosage form | Lotion |
| Route | Topical |
| Company | Vortech Pharmaceuticals Ltd. |
| Status | Cancelled Post Market — 18 Oct 1996 |
| Class | Veterinary |
| ATC | |
| AHFS | 28:16.08.24 |
| Regulator record | Health Canada DPD entry · Product monograph |
Boric Acid registered in other markets
11 registrations of the same molecule in 5 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Hong Kong | St Luke's Baby Powder 2.5% | Chiu Fat Trading Company Limited | Registered | DH Drug Office | ||
| Taiwan | Boric Acid | Eli. Lilly & Co. | （粉） | 已註銷 | TFDA | |
| Taiwan | Boric Acid U.s.p.xv "K.y." | 洸洋化學製藥股份有限公司 | 散劑 | 已註銷 | TFDA | |
| Taiwan | Mytear Eye Lotion | 杏輝藥品工業股份有限公司 | 點眼液劑 | 已註銷 | TFDA | |
| United Arab Emirates | Eva Intima Myco Cleansing Fluid | IOULIA & IRENE TSETI PHARMACEUTICAL LABORATORIES S.A (d.t. INTERMED S.A.), Greece, Attiki | combination | Liquid | Active | EDE |
| United Arab Emirates | Eva Intima Mycosis Ovules | IOULIA & IRENE TSETI PHARMACEUTICAL LABORATORIES S.A (d.t. INTERMED S.A.), Greece, Attiki | combination | Pessary | Active | EDE |
| United Kingdom | Boric acid 2% ear drops | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Boric acid 300mg vaginal capsules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Boric acid 600mg pessaries | — | 0001 | NHS dm+d VMP | ||
| United States | Boric acid | Merck KGaA | Powder | FDA NDC | ||
| United States | V-Bella | U.s. Pharmaceutical Corporation | Suppository | listed | FDA NDC |
See every manufacturer of Boric Acid worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Bovilix (DIN 00775290) marketed in Canada?
No. Health Canada lists DIN 00775290 as Cancelled Post Market as of 18 Oct 1996.
Who holds the Canadian licence for this product?
Vortech Pharmaceuticals Ltd. is the company of record in the Health Canada Drug Product Database.
Is Boric Acid registered outside Canada?
Yes — Nexara Health has matched 11 registrations in 5 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00775290, status date 1996-10-18; national medicine registries: DH Drug Office, EDE, FDA NDC, NHS dm+d VMP, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00775290, status date 1996-10-18; national medicine registries: DH Drug Office, EDE, FDA NDC, NHS dm+d VMP, TFDA.
Health Canada Drug Product Database (DPD), DIN 00775290, status date 1996-10-18; national medicine registries: DH Drug Office, EDE, FDA NDC, NHS dm+d VMP, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.